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Objective(s): Involvement of tyrosinase in the synthesis of melanin and cell signaling pathway 
has made it an attractive target in the search for therapeutic inhibitors for treatment of different 
skin hyperpigmentation disorders and melanoma cancers.  
Materials and Methods: In the present study, we conducted a comprehensive kinetic analysis to 
understand the mechanisms of inhibition imposed by 2-amino benzoic acid, 4-amino benzoic 
acid, nicotinic acid, and picolinic acid on the monophenolase and diphenolase activities of the 
mushroom tyrosinase, and then MTT assay was exploited to evaluate their toxicity on the 
melanoma cells. 
Results: Kinetic analysis revealed that nicotinic acid and picolinic acid competitively restricted 
the monophenolase activity with inhibition constants (Ki) of 1.21 mM and 1.97 mM and the 
diphenolase activity with Kis of 2.4 mM and 2.93 mM, respectively. 2-aminobenzoic acid and 4-
aminobenzoic acid inhibited the monophenolase activity in a non-competitive fashion with Kis of 
5.15 µM and 3.8 µM and the diphenolase activity with Kis of 4.72 µM and 20 µM, respectively. 
Conclusion: Our cell-based data revealed that only the pyridine derivatives imposed cytotoxicity 
in melanoma cells. Importantly, the concentrations of the inhibitors leading to 50% decrease in 
the cell density (IC50) were comparable to those causing 50% drop in the enzyme activity, 
implying that the observed cytotoxicity is highly likely due to the tyrosinase inhibition. 
Moreover, our cell-based data exhibited that the pyridine derivatives acted as anti-proliferative 
agents, perhaps inducing cytotoxicity in the melanoma cells through inhibition of the tyrosinase 
activities. 
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Introduction 
Tyrosinase (EC 1.14.18.1) is a copper-containing 
bifunctional enzyme, widely distributed in mammals, 
plants and micro-organisms (1). This enzyme 
catalyzes hydroxylation and oxidation of mono-
phenols and diphenols, respectively (2). In fact, it 
catalyzes the hydroxylation of tyrosine to form 3,4-
dihydroxyphenylalanine (L-DOPA), and L-DOPA to 
DOPA quinine (3). Quinones, in turn, develop 
chemically to melanins and other polyphenolic 
compounds (4).  
Engagement of tyrosinase in important cell 
signaling pathways has made the enzyme an 
attractive target in the search for therapeutic 
inhibitors for prevention and treatment of different 
disorders including skin hyperpigmentation and 
cancers (5, 6). In addition, inhibition of tyrosinase 
with various kinds of inhibitors has been a useful 
tool for gaining better understanding of the 
mechanism of action of the enzyme (7, 8). In the past 
decade, a large number of compounds such as 
benzaldehyde and benzoate derivatives have been 
identified that inhibit the enzyme activity (9–16). It 
is known that the aldehyde group in the 
benzaldehyde derivatives react with functional 
groups including hydroxyl, amino and sulfhydryl 
group (9, 10). Previous studies have indicated that 
benzaldehyde inhibitors restrict the enzyme activity 
by forming a Schiff base with a primary amino group 
in the enzyme structure (14, 15). It has also been 
suggested that benzoate inhibits tyrosinase by a 
copper chelating mechanism (16). It is thought that 
 
*Corresponding author: Dariush Ilghari. Department of Clinical Biochemistry and Genetics, Qazvin University of Medical Science, Qazvin, Iran. email: 
d.ilghari@gmail.com
Inhibition of aromatic acid derivatives on tyrosinase                                                                                                                                                      Gheibi et al    
 
 Iran J Basic Med Sci, Vol. 18, No. 2, Feb 2015   
 
123 
            
 
       (a)                          (b)                            (c)    
     
          
 
           (d)                         (e)                           (f) 
 
Figure 1. The chemical structures of substrates and inhibitors of 
Mushroom tyrosinase MT used in this study. a) 2-amino benzoic 
acid b) 4-amino benzoic acid c) caffeic acid d) picolinic acid e) p-
coumaric acid f)nicotinic acid 
 
carboxyl group in the molecular structure of 
benzoate acts as a nucleophile, perhaps chelating 
Cu2+, the essential cofactor of tyrosinase (17). 
Although aromatic derivatives, including benzoate 
and pyridine ones, reversibly restrict tyrosinase 
activity (9, 10), the mechanisms of inhibition through 
which they exert their inhibitory effects are not fully 
understood. In the present work, we, therefore, 
accomplished comprehensive kinetic analysis to gain 
better understanding of the mechanisms by which 
some aromatic derivatives including 2-amino benzoic 
acid, 4-amino benzoic acid, nicotinic acid, and picolinic 
acid restrict the mushroom tyrosinase activity. To do 
so, we kinetically analyzed both monophenolase and 
diphenolase activities of the enzyme in presence and 
absence of the inhibitors using spectroscopic 
methods. In addition, to check whether these 
inhibitors were able to induce cytotoxicity, the 
melanoma cell lines were treated with the inhibitors 
at the concentration range that they imposed their 
inhibitory effects on the purified mushroom 
tyrosinase. Our data clearly demonstrated that the 
aromatic derivatives reversibly inhibited 
monophenolase and diphenolase activities of the 
enzyme and despite the close structural similarity 
(Figure 1), these analogues showed differences in 
mechanism of inhibition. Importantly, our data clearly 
showed that only nicotinic acid and picolinic acid had 
cytotoxic effects on the melanoma cells. 
   
 
Materials and Methods 
Materials 
MT (mushroom tyrosinase: EC 1.14.18.1) were 
prepared as previously described (18). P-
hydroxycinnamic (p-coumaric acid λ max = 288 nm,               
ε= 19400 M-1. cm-1), 3,4-dihydroxycinnamic acid 
(caffeic acid, λ max = 311 nm, ε =12000 M-1. cm-1), 4-
amino benzoic acid, 2-amino benzoic acid, nicotinic  
acid, and  picolinic acid were purchased from Sigma. 
All other reagents were homemade analytical grade. 
The water used was re-distilled and ion-free; 
spectrophotometric measurements were carried out 
using a Rayleigh model 2100 spectrophotometer. 
The chemical formulas of all compounds (substrates 
and inhibitors) used in this research are given in 
(Figure 1). The buffer used throughout this research 
was 15 mM phosphate buffer solution (PBS), pH=6.8, 
and the corresponding salts were obtained from 
Merck. All experiments were carried out at 293 K 
and all solutions prepared in doubly distilled water. 
Freshly prepared enzyme and substrate solutions 
were used in this work. 
 
Enzyme reactions 
All enzymatic reactions were run in phosphate 
buffer (10 mM) at pH=6.8, in a conventional quartz 
cell, thermostated to maintain the temperature at 
20±0.1°C. The selected conditions of solvent, buffer, 
pH, temperature, and enzyme concentration were 
applied for assaying the oxidase activity of MT 
according to our previous studies (19-20). Cresolase 
reactions were measured by depletion of p-coumaric 
acid for 10 min at λ max=288 nm and enzyme 
concentration of 70.8 μM, 240 unit/ml. The reactions 
were followed using six different fixed 
concentrations of substrate (5–50 μM) at different 
concentrations of acids as inhibitors. Catecholase 
activity was followed by depletion of caffeic acid for 
2 min at λ max = 311 nm and enzyme concentration of 
11.8 μM, 40 unit/ml at different concentrations of 
acids as inhibitors. The reactions were carried out 
using fixed concentration of substrate (50 μM) at 
different concentrations of acids. All assays were 
repeated at least three times. Substrate was added 
when the incubation time (2 min) for the mixture of 
enzyme with each concentration of inhibitors was 
completed. Definitions of units were given by the 
vender. Accordingly, one unit cresolase activity was 
equal to 0.001 change in optical density of L-tyrosine 
per minute at 280 nm in 3 ml of the reaction mixture 
at 25°C and pH= 6.5. Similarly, one unit of 
catecholase activity was equal to 0.001 change in 
optical density of ascorbic acid per minute at 265 nm 
in 3 ml of the reaction mixture (25°C and pH = 6.5), 
when catechol or L-DOPA were used as substrates. 
 
Inhibition analysis 
The Michaelis constant (Km) and maximum 
velocity (Vmax) of the tyrosinase were determined by 
the Lineweaver-Burk plots. The velocity equation for 
the competitive inhibition in reciprocal form is: 
1/V=Km/Vmax(1 + [I]/Ki)1/[S]+1/Vmax. 
 The inhibition constants (Ki) of the competitive 
inhibitors were calculated by the following equation: 
Km, app = Km [1+([I]/Ki)], where Km, app is the apparent 
Km in the presence of an inhibitor. The reciprocal 
equation for the noncompetitive inhibition is: 
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1/V=Km/Vmax(1+[I]/Ki)1/[S]+1/Vmax(1+[I]/Ki). Ki of 
the noncompetitive inhibitors were calculated using 
the following equation: 1/Vmaxapp = (1+[I]/Ki) /Vmax, 
where Vmaxapp is the apparent Vmax in the presence of 
an inhibitor. 
 
Cytotoxicity assay 
Melanoma cell lines (NCBI Code: C136; human 
skin) were grown in RPMI1640 (Gibco, No 51800-
019) medium supplemented with 10% fetal bovine 
serum (FBS). The stock solutions of 2-amino benzoic 
acid, 4-amino benzoic acid, nicotinic acid, and 
picolinic acid were prepared by dissolving the 
compound in 100 µl isopropanol and then dissolved 
by PBS buffer. The different concentrations of 
aromatic acids were prepared and treated with the 
melanoma cell lines. Cells were plated in the 
appropriate media on 24-well micro plates in a 500 
μl total volume at a density of 104 cell/ml. Triplicate 
wells were treated with media containing different 
concentrations of the extracts. The plates were 
incubated at 37°C in 5% CO2 for time course of 24 hr. 
Cell viability was evaluated by the MTT colorimetric 
technique (21). The OD570 was determined using a 
microplate reader. Media- only treated cells served 
as the indicator of 100% cell viability. The required 
concentration (IC50) of CAPE that can lead to 50% 
decrease in melanoma cell viability 24 hr after 
incubation was calculated from the logarithmic 
regression equation derived from graphing the 
viability of the cells at 24 hr versus the concentration 
of aromatic acids. The calculated concentration was 
then used to guide further selection of aromatic acid 
concentrations for fine tuning of IC50 determination, 
experimentally. Viability percentage was evaluated 
as (OD treatment/ OD control) ×100 (22). 
 
Results 
Characterization of inhibitory effect of the benzoic 
acid and pyridine derivatives on the 
monophenolase activity of mushroom tyrosinase 
The inhibition kinetics of benzoic acid (2-amino 
benzoic acid and 4-amino benzoic acid) and pyridine 
derivatives (nicotinic acid and picolinic acid) on the 
monophenolase activity of the mushroom tyrosinase 
were investigated using p-coumaric acid as substrate 
and then the kinetic parameters for the enzyme were 
acquired from Lineweaver–Burk double reciprocal 
plots and the secondary plots of the slope versus 
concentration of inhibitors (Figures 2A–2D). 
 
                     
                     
Figure 2. Double reciprocal Lineweaver-Burk plots of MT kinetic assay for monophenolase reactions. p-coumaric acid was a substrate. The 
reaction was done in 10 mM PBS, pH 6.8, at 20°C and 70.8 μM enzyme, in the presence of different concentrations of (A) 2-amino benzoic 
acid: 0 μM (■), 4 μM (▲), 8 μM (×), 12 μM (Ж), 16 μM (♦); (B) 4-amino benzoic acid: 0 μM (■) 5 μM (▲), 10 μM (×), 20 μM (Ж), 30 μM (♦); 
(C) nicotinic acid: 0 mM (■) 1mM (▲), 1.5 mM (×), 2 mM (Ж), 2.5 mM (♦) and (D) picolinic acid : 0 mM (■) 2 mM (▲), 4 mM (×), 6 mM (Ж), 
8 mM (♦). Inserts: secondary plots, the slope against different concentrations of inhibitor, which gives the inhibition constant (−Ki) from the 
abscissa-intercepts 
 
A B 
C D 
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Our kinetic data showed that, under the 
conditions used in this study, the monophenolase 
activity followed the Michaelis–Menten kinetics 
(Figures 2A–2D). These data also demonstrated that, 
similar to 2-amino benzoic acid (Figure 2A), 4-amino 
benzoic acid inhibited the monophenolase activity 
reversibly in a noncompetitive manner (Figure 2B). 
This is evidenced by the fact that increasing the 
concentration of the inhibitors led to a set of lines 
with different slopes, intercepting one another at a 
common point on the X- axis (Figures 2A and 2B). 
The equilibrium constants for binding of inhibitors to 
the free enzyme or enzyme-substrate complex, Ki, 
were obtained from the plots of the slope lines 
versus the concentration of the inhibitors, which 
were linear (Figures 2A and 2B; inserts). As 
summarized in Table 1, the calculated constants 
were 5.15 µM and 3.8 µM for 2-amino benzoic acid 
and 4-amino benzoic Acid, respectively. 
Similar kinetic analysis was performed to 
characterize inhibitory effects of nicotinic acid and 
picolinic acid on the enzyme's monophenolase 
activity. From our kinetic data, it appeared that both 
inhibitors restricted the monophenolase activity 
reversibly in a competitive fashion (Figures 2C and 
2D). This is confirmed by the Lineweaver–Burk 
double reciprocal plots, showing that increasing the 
concentration of the inhibitors results in a family of 
lines with different slopes, intercepting one another 
at a common point on the Y-axis (Figures 2C and 2D). 
The inhibition constants for binding of these 
inhibitors to the free enzyme (E) were calculated 
from the secondary plots of the slope versus 
concentrations of the inhibitors (Figures 2C and 2D; 
inserts), which were also linear. As tabulated in 
Table 1, the obtained Kis were 1.21 mM and 1.97 mM 
for nicotinic acid and picolinic acid, respectively. 
Consistent with the calculated Kis, the inhibitory 
concentration of the inhibitors, leading to 50% 
monophenolase activity lost (IC50), were estimated to 
be 5.15 µM, 3.8 µM, 3.41 mM and 3.55 mM for 2-
amino benzoic acid, 4-amino benzoic acid, nicotinic 
acid, and picolinic acid, respectively (Table 1). 
 
Characterization of inhibitory effects of the 
benzoic acid and pyridine derivatives on the 
diphenolase activity of mushroom tyrosinase 
The kinetic behavior of mushroom tyrosinase was 
studied during the oxidation of caffeic acid as 
substrate. Under the conditions employed in this 
work, the oxidation reaction of caffeic acid by 
mushroom tyrosinase followed the Michaelis–Menten
 
                       
                       
Figure 3. Double reciprocal Lineweaver-Burk plots of MT kinetic assay for diphenolase reactions. caffeic acid   was a substrate. The 
reaction was done in 10 mM PBS, pH 6.8, at 20oC and 11.8 μM enzyme, in the presence of different concentrations of (A) 2-amino benzoic 
acid: 0 μM (■), 4 μM (▲), 8 μM (×), 12 μM (Ж), 16 μM (♦); (B) 4-amino benzoic acid: 0 μM (■), 4 μM (▲), 8 μM (×), 12 μM (Ж), 16 μM (♦); 
(C) nicotinic acid: 0 mM (■) 1 mM (▲), 2 mM (×), 3 mM (Ж), 4 mM (♦), and (D) picolinic acid: 0 mM (■) 2 mM (▲), 4 mM (×), 6 mM (Ж), 8 
mM (♦). Inserts: secondary plots, the slope against different concentrations of inhibitor, which gives the inhibition constant (−Ki) from the 
abscissa-intercepts 
A B 
C D 
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Table 1. Inhibition parameters obtained from kinetic investigations of mushroom tyrosinase with and without presence of 2- and 4-amino 
benzoic, nicotinic and picolinic acids  
Picolinic acid Nicotinic acid 4-amino benzoic acid 2-amino benzoic acid Constants 
3.54 mM 3.41 mM 3.8 μM 5.15 μM IC50(Monophenolase)  
3.69 mM 3.8 mM 20 μM 4.72 μM IC50  (Diphenolase) 
1.97 mM 1.21 mM 3.8 μM 5.15 μM Ki (Monophenolase) 
2.93 mM 2.4 mM 20 μM 4.72 μM Ki (Diphenolase) 
reversible reversible reversible reversible Inhibition 
competitive competitive noncompetitive noncompetitive Inhibition type 
 
 
kinetics (Figures 3A-3D). The results illustrated in 
Figures 3A and 3B show that 2-amino benzoic acid 
and 4-amino benzoic acid inhibited the tyrosinase 
diphenolase activity reversibly in a noncompetitive 
way. This is evident by the fact that increasing the 
concentration of the inhibitors resulted in a family of 
lines with different slopes, intercepting one another 
at a common point on the X axis (Figures 3A and 3B). 
The equilibrium constants for binding of inhibitors 
with free enzyme or enzyme-substrate complex were 
obtained from a plot of the slope lines versus the 
inhibitor concentration, which were linear (Figures 
3A and 3B; inserts). The obtained Kis were 4.72 µM 
and 20 µM for 2-amino benzoic acid and 4-amino 
benzoic acid, respectively (Table 1). The Kis were 
fully consistent with the estimated IC50s, which were 
about 4.72 µM and 20 µM for 2-amino benzoic acid 
and 4-amino benzoic acid, respectively (Table 1). 
Further kinetic analysis revealed that both 
nicotinic acid and picolinic acid restricted reversibly 
the diphenolase activity of the enzyme in a 
competitive manner (Figures 3C and 3D). This is 
evidenced by the Lineweaver–Burk double 
reciprocal plots, showing that increasing the 
concentration of the inhibitors led to a family of lines 
with different slopes, intercepting one another at a 
common point on the Y-axis (Figures 3C and 3D). Kis 
for binding of these inhibitors to the free enzyme (E) 
were also estimated from the secondary plots of the 
slope versus concentrations of the inhibitors, which 
were linear (Figures 3C and 3D; inserts). The 
calculated Kis were 2.4 mM and 2.93 mM for 
nicotinic acid and picolinic acid, respectively (Table 
1). In line with the Kis, IC50s were estimated to be 3.8 
mM and 3.7 mM for nicotinic acid and picolinic acid, 
respectively (Table 1).  
 
Cytotoxicity on the melanoma cells  
To evaluate whether the inhibitors are able to 
contain proliferation of melanoma cells, the 
melanoma cell lines were treated with various 
concentrations of 2-amino benzoic acid, 4-amino 
 
 
 
Figure 4. Cell viability of melanoma cell line after 24 hr treatment with different concentrations of 2- and 4-amino benzoic acid, nicotinic 
acid, and picolinic acid 
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benzoic acid, nicotinic acid and picolinic acid and 
then the cell viability was analyzed by measuring the 
microwell cell density using a microplate reader 
(Figure 4). Media-only treated cells served as the 
indicator of 100% cell viability.  As shown in Figure 4, 
treatment of the cell lines by 2-amino benzoic acid 
and 4-amino benzoic acid caused no significant 
change in the cell viability. On the contrary, presence 
of nicotinic acid and picolinic acid in the microwells 
declined remarkably the viability of the melanoma 
cells in a dose-dependent manner (Figure 4). This is 
evidenced by the fact that increasing the 
concentrations of nicotinic and picolinic acids from 0 
to 8 mM led to an 80% drop in the melanoma cell 
viability (Figure 4). The concentrations at which the 
inhibitors reduced the cell density up to 50% (IC50) 
were 3.61 mM and 2.42 mM for nicotinic acid and 
picolinic acid, respectively. 
 
Discussion 
In the present work, we characterized the 
inhibitory effects of the potential therapeutic 
inhibitors, i.e. benzoic acid (2-amino benzoic and 4-
amino benzoic acids) and pyridine (nicotinic and 
picolinic acids) derivatives, on the diphenolase and 
monophenolase activities of mushroom tyrosinase. 
Consistent with previous studies (9, 10, 17, 23), our 
comprehensive kinetic analyses explicitly showed 
that the inhibitors restricted reversibly both 
diphenolase and monophenolase activities of the 
enzyme. For the monophenolase activity, 2-amino 
benzoic acid and 4-amino benzoic acid inhibited the 
enzyme activity in a noncompetitive fashion, whereas 
nicotinic acid and picolinic acid competitively 
restricted the enzyme activity. Additionally, 
comparison of the calculated Kis suggested that the 
inhibitors imposed their inhibitory effect on the 
monophenolase activity with the potencies ranking as 
follows: picolinic acid ≤ nicotinic acid << 2-amino 
benzoic acid < 4-amino benzoic acid. Similarly, the 
benzoic acid and pyridine derivatives inhibited the 
diphenolase activity in noncompetitive and 
competitive manners, respectively, with inhibitory 
potencies ranking as follows: picolinic acid ≤ nicotinic 
acid << 4-amino benzoic acid ≤ 2-amino benzoic acid. 
The observed trends in inhibitory potencies of the 
inhibitors were supported by the estimated IC50s of 
the monophenolase and diphenolase activities, 
confirming that the benzoic acid derivatives have 
significantly greater inhibitory effects on the enzyme 
activities as compared to the pyridine compounds. 
The non-competitive inhibitions exerted by the 
benzoic acid derivatives suggest that they bind to a 
site other than the active site of the enzyme and 
interact with either free enzyme (E) or the enzyme-
substrate complex (ES), thus forming a non-
productive complex (ESI). Furthermore, the 
competitive inhibitions imposed by the pyridine 
derivatives indicate that the inhibitors combine only 
with the free enzyme, competing with the substrate 
for binding to the active site of the enzyme.    
Search for nontoxic, potent tyrosinase inhibitors 
has been the subject of extensive studies (24). Among 
the nontoxic and potentially therapeutic inhibitors of 
tyrosinase, aromatic compounds have gained much 
attention due to their potential applications in the 
cosmetic industry and medicinal purposes (8, 24–27). 
It has been previously suggested that some of these 
compounds impair melanin synthesis and DNA 
repair, and even act as anti-proliferative agents by 
interfering with tyrosinase and the melanocyte 
stimulating hormone receptor (MC1R) activity (8, 26–
27). Given that the benzoic acid and pyridine 
derivatives used in this study inhibit potently the 
tyrosinase activity; it is tempting to hypothesize that 
these particular aromatic derivatives could also 
restrict proliferation of the melanoma cells. To check 
our hypothesis, we treated the melanoma cell lines 
with increasing concentrations of inhibitors and then 
the cell viability was assessed using MTT assay 
(Figure 4). Our data showed that only pyridine 
derivatives were able to induce cytotoxicity in the 
melanoma cell lines (Figure 4). This finding was fully 
in agreement with those from previous reports, 
suggesting nicotinic acid and picolinic acid as anti-
proliferative agents (28–30).  Raising concentrations 
of nicotinic acid and picolinic acid (from 0 to 8 mM) 
resulted in a significant decrease (about 80%) in the 
melanoma cell viability. The concentrations of the 
inhibitors, leading to 50% decrease in the cell density 
(IC50), were very close and comparable to those 
resulting in 50% drop in the monophenolase and 
diphenolase activities, suggesting that the observed 
cytotoxicity is likely due to the tyrosinase inhibition. 
In line with previous studies (31), our cell-based 
analysis showed that the particular benzoic acid 
derivatives applied in the present work led to no 
significant cytotoxic effect on the growth of the 
melanoma cells (Figure 4). Since the applied benzoic 
acid derivatives can be absorbed by melanoma cell 
lines (31), it is reasonable to speculate that these 
compounds were not reachable by the cellular 
tyrosinase, hence were unable to impose their 
inhibitory effects on the enzyme activity. It is well-
known that the benzoic acid can be converted to 
nontoxic hippuric acid in the liver and kidney cells 
(32). Similarly, it is possible that 2-amino and 4-
amino benzoic acids are transformed to various 
ineffective metabolites, which are unable to limit the 
enzyme activities within melanoma cells. This, along 
with the possibility that the benzoic acid derivatives 
interact with high affinity with cellular proteins 
other than tyrosinase, perhaps reduce significantly 
effective concentrations of these derivatives 
required for inhibition of the enzyme activities.  
 
Conclusion 
Collectively, we characterized mechanisms of 
inhibition by which the benzoic acid and pyridine 
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derivatives exert their inhibitory effects on the 
monophenolase and diphenolase activities of 
mushroom tyrosinase. Despite similar molecular 
structures, our kinetic data demonstrated that the 
applied benzoic acid and pyridine derivatives 
inhibited the tyrosinase activities with different 
mechanisms. In fact, the pyridine derivative 
restricted the enzyme activities in a competitive 
fashion, whereas their benzoic acid counterparts 
imposed their inhibitory effects in a non-competitive 
manner. Moreover, our cell-based data showed that 
the pyridine derivatives acted as anti-proliferative 
agents, inducing cytotoxicity in melanoma cell lines 
probably by inhibition of the tyrosinase activities. 
Given these findings, nicotinic acid and picolinic acid 
could be considered as the potential therapeutic 
inhibitors for the treatment and prevention of 
melanoma and skin hyperpigmentation disorders. 
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